Introduction
Since the millennium development goals (MDGs) were adopted at the United Nations Millennium Summit in 2000, governments, international institutions, and donors have demanded accurate data for monitoring MDG progress (1) . However, lack of quality data in low-and middle-income countries is widely acknowledged as an ongoing challenge. Accurate data contribute to identifying health gaps and priority for health investment on global targets (2) . To facilitate tracking of progress of health systems over time and to make comparisons across countries, international statistics experts have produced global health estimates (GHEs), despite encountering the country data shortfall (3) .
At the conclusion of the MDG era in 2015, countries adopted the sustainable development goals (SDGs). These goals are far more ambitious and extensive in scope than the MDGs, and they place significant demands on countries to monitor progress toward the SDG targets regularly until 2030 (4) . , allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for any purpose, even commercially, provided the original work is properly cited and states its license.
Global Health Action
Because of the ongoing inadequacies in the availability and quality of country data, GHEs will continue to be needed for monitoring SDG progress. Yet, GHEs cannot replace the need for improved data infrastructure and capacities in countries where there is a lack of data or poorquality data. As the production of GHEs continues to expand, the challenge is to assess the extent to which a GHE can be used to improve the availability and quality of data and to support policy decisions at the country level.
This study discusses lessons learned from experience on the capacity development of national health estimates (NHEs) through the burden of disease (BOD) program in Thailand and discusses the contributions and limitations of GHEs in informing policies at the country level.
Experiences of NHE: Thai BOD

Policy demands for a national BOD in Thailand
Since the World Development Report 1993 'investing in health'(5) was published, Thai policymakers have become more familiar with the concept of disability-adjusted life year (DALY), a summary measure of fatal and nonfatal health outcomes in a population. There is a growing consensus of the potential value of such measures for policy and planning (6Á9). Interest in the BOD was also stimulated by consultations among member states on health system performance assessment for which BOD is one of the critical components (10) . The World Health Organization (WHO) has invested in a series of technical workshops providing training and capacities building for member states on the development of BOD.
The first study on BOD in Thailand was completed in 1997 (11) and was supported by the Health Systems Research Institute. The study has limitations regarding quality of data; the data were mainly derived from the mortality and morbidity database at the Health Statistics Division of the Ministry of Public Health (MOPH).
BOD requires exhaustive data including mortality, incidence, prevalence of all diseases in a population, the age at onset, duration, and disease progression. Thailand has a well-designed health information system (HIS) (12) . There are two types of HIS data: populationbased and health facilityÁbased datasets. Populationbased data sources comprise the civil registry, population census, and household surveys regularly conducted by the National Statistical Office (NSO). Facility-based data cover health service records, disease notification surveillance systems, and certain disease registries.
Mortality statistics are essential for the estimate of BOD, in particular the year of life loss (YLL) and related causes. Problems arose when it became apparent that more than 40% of reported deaths were ascribed to 'ill-defined' causes or 'garbage codes' as referred by the Global Burden of Disease (GBD) report (13) . The MOPH recognized the need to improve the quality of cause-of-death (COD) ascertainment. In response, it convened the first national verbal autopsy (VA) study to determine COD on those who died in 2000 without proper medical certification. The initial plan was to improve the accuracy of COD information in the routine death registration system by introducing a system of medical certification for deaths occurring at home in parallel with regular VA studies to enable adjustment of the routine data. However, this plan has not been progressing well because of the complexity of coordination in the field and the scant policy and funding support from the MOPH. In practice, the results from the VA study were used to verify and reestimate COD in the 1999 Thai BOD estimation, followed by the 2004 BOD report (14) .
The BOD uses a variety of sources of morbidity data that are collected by different authorities both within and outside the MOPH. Continued effective intersectoral collaboration among related agencies and the private sector provider is required.
Assessment of data quality for BOD Because the BOD estimates both fatal and non-fatal health outcomes in a population, it is essential to understand the potential measurement bias from various sources of data. The first step of BOD estimation is to assess the quality of data in terms of completeness and accuracy (Table 1) .
The civil registration system records almost all deaths and is the main source of mortality statistics in Thailand; thus, it is the key contributor to the accuracy of YLL estimates. An assessment supported by University of Queensland in Australia and WHO in 2012 rated the Thai registration system as 'satisfactory', requiring minor adjustments in an otherwise well-functioning system (15) . The survey of population change, conducted every decade (intercensus survey) by the NSO, reported 2 and 5% incompleteness of mortality registration in 2005Á2006 and 1995Á1996, respectively (16, 17) . However, higher levels (e.g. 8.69%, 95% CI 0 8.65Á8.72%) of incompleteness were found in other studies (18, 19) by a dual-records system estimation (18) . Use of indirect demographic methods found higher levels of incompleteness in mortality registration (20) . Inaccurate COD assignment for each mortality event is an unresolved problem, as 49% of deaths during 1950Á2000 were coded as ill defined (13) .
The disease notification surveillance system has regularly produced the Weekly Epidemiological Surveillance Report (WESR) since 1970 by the MOPH Bureau of Epidemiology (21) . The WESR covers all major communicable diseases such as HIV/AIDS, diarrhea, and tuberculosis. It is intended to provide timely information on disease outbreaks for control and response purposes, and it publishes data on notifiable disease patterns and trends nationwide. Its strength is the accuracy of disease case reporting, timeliness, and rapid response. The time series data are useful for trends analysis of epidemics. However, the system has important limitations. In particular, there Kanitta Bundhamcharoen et al. is incomplete coverage of surveillance and reporting of notifiable diseases because most of the public non-MOPH and private hospitals and clinics do not adhere to reporting standards, despite that a significant proportion of services for urban populations are provided by this sector.
The Universal Coverage Scheme (UCS) introduced in 2002 requires the payment system to include individual service use data (22, 23) . This system has resulted in significantly improved accuracy of clinical diagnosis in institution-based services. In addition, there has been considerable improvement in data infrastructure including hardware, software, and regular capacity building and auditing. A data auditing system helps ensure accuracy of the data. The National Health Security Office (NHSO) collects data on services rendered to beneficiaries covered by the UCS, representing more than 75% of the total population.
Population-based surveys are an indispensable source of data on population coverage, complementing the institutional coverage rates estimated from routine clinical data collection. The NSO conducts nationally representative household surveys regularly, in particular, the Health and Welfare Survey (HWS). The National Health Examination Survey (NHES), conducted every 5 years, contributes significantly to data generation for specific disease conditions. However, surveys based on interviews have limitations because of recall bias and lack of specificity and sensitivity for specific disease diagnoses. Because the NHES includes clinical/biomedical measurements, it provides more accurate diagnoses, although at a significantly higher cost.
Capacity development and institutionalization of NHE
After the publication of the first GBD estimates in 1997 (24) , the WHO convened a series of training workshops bringing together researchers and health managers from several member states. The workshops were useful in capacity building for Thai researchers and health managers. In 2000, the Thai MOPH conducted the first estimation of Thai BOD, establishing a BOD working group with joint financial support from the WHO country office and setting up the first national VA study (25) . The work was undertaken with technical support from academic institutions in Australia and financial support from Australian Agency for International Development. The first BOD report in Thailand was published in 2002, and it attracted the attention by the MOPH's high-level executives and relevant stakeholders (26) . Recognizing its usefulness, policymakers endorsed the continued BOD estimate.
The success of the first study brought about a new funding opportunity from the Wellcome Trust and the creation of a project call 'Setting Priority Using Information on Cost-Effectiveness' (SPICE) (27) . SPICE is a joint collaboration between a group of Thai researchers and the University of Queensland. The project included a capacitybuilding program awarding master's and doctorate fellowships from the University of Queensland. Importantly, the second national VA study was undertaken under the auspices of this project (27) , and the findings were applied to the 2004 national BOD study.
The institutionalization of the national BOD was gradually achieved, largely with funding support from the ThaiHealth Foundation. Today, the BOD is a major program within the International Health Policy Program, an internationally well-known program because of its engagement in health system and policy research. The BOD program contributed significantly to many health promotion research programs, including the Centre for Alcohol Study, Food and Health Promotion Policy, and non-communicable, chronic disease (NCD) networking programs; these programs were developed with support from the ThaiHealth Foundation. Evidence from the BOD also supports further research work in these research programs.
In addition to the BOD estimates at national level, further work includes subnational analysis (28, 29) . This is particularly useful for situation analysis and benchmarking across 77 provinces and 13 public health regions. In 2009, total DALYs lost for 63.4 million populations in the whole country was 10.2 million. Region 1, a cluster of eight upper northern provinces, had the highest DALYs rate and the lowest rate was in the Bangkok metropolitan region, ranging from 34% higher and 24% lower than the national DALY rate, respectively. It also reveals different patterns of disease burden across the health regions. Although this is useful for policymaking at the health region, quality of COD and completeness of morbidity have yet to be strengthened.
Quality improvement of mortality data
The quality of COD is unsatisfactory because the majorities of deaths occurred at home and were reported by laypersons (30) . Death with underlying causes coded to 'garbage codes' (13) was high at 53% in 1999 (59% of total home deaths, 34% of total hospital deaths). After the first VA in 1999, several actions have been undertaken by the MOPH, including several types of training for health personnel working in hospitals and health centers. An intervention that aimed to have all home deaths certified by medical personnel was not successful due, in part, to limited staff capacity. Subsequently, a shortened VA was introduced for health center personnel to interview the decedent's relatives before getting death registered. However, this was not well received as it lengthened the process of death registration. Later, the registrar was trained to be aware of accuracy of COD and use a shorten VA to improve it. However, there is considerable variation in how this training is implemented in practice.
Policy utilities of NHE
The first BOD estimates greatly raised awareness among policymakers in MOPH by generating evidence on HIV/ AIDS as the leading cause of premature death in 1999, followed by road traffic injuries, and stroke (26) . The vital registration system reported only 6.4 thousand deaths due to HIV/AIDS, compared with the BOD estimate of 51.1 thousand. This was the first national estimation of mortality due to HIV/AIDS, apart from the Asian Epidemic Model (31) . The BOD exercise not only generated new data but also presented in the information in a way that was readily interpretable from a policy perspective. For example, in contrast to routine health statistics reports, the BOD data were offered in diverse formats such as leading causes of death and DALYs by age and sex and by ranking of the proportion of deaths by cause. The BOD exercise also adjusted COD distributions obtained from the routine vital registration by VA studies. These factors rendered the BOD estimates more compelling for policymakers.
The 1999, BOD rankings of CODs and disabilities were cited in the majority of health policy and strategic plan documents, such as the 5-year national socioeconomic development plan, the MOPH strategic plan, and other statistical references (32Á37). Based on the estimates of attributable risk fractions generated by the BOD exercise, public health priorities were increasingly directed toward tobacco control, alcohol abuse, prevention of road traffic injuries, and drug addiction. During the period 2001Á2005, several health reforms were undertaken simultaneously that required BOD evidence. Among these reforms were the establishments of the ThaiHealth Foundation in 2001 and the NHSO in 2002.
The evidence from the 1999 Thai BOD report, by showing the shifting disease burden to NCDs, injuries, and mental health disorders, illuminated the need for effective health promotion interventions (38) . From its origins in tobacco control, the ThaiHealth Foundation was established by law as a public organization with its own legal status and governing body. It was chaired by the prime minister, with funding from a 2% surcharge on alcohol and tobacco excise tax. The establishment of ThaiHealth Foundation has enabled innovative health promotion programs with various stakeholders outside the MOPH and has supported effective intersectoral actions.
Thailand is increasingly adopting an evidence-based policy strategy in health that requires solid documentation of the magnitude of a problem and the ability to monitor and evaluate intervention effectiveness. For example, evidence from the BOD provides the foundation for the MOPH strategic plan and its various departments, including Disease Control, the ThaiHealth strategic plan, key performance indicators of the NHSO, and the national NCD and risk control plan. Furthermore, based on evidence from the BOD, health-adjusted life expectancy was set as a target in the 10-year strategic plan for the ThaiHealth Foundation and the MOPH (32, 35) .
Although the measure of DALYs lost was cited as a major priority setting criterion for health interventions in many of the MOPH's policy and planning documents, it is not considered feasible to use as an outcome indicator because it is, by its nature, a summary measure and is based on complex and time-consuming methods. Instead, the MOPH uses routine statistics, in particular, mortality and morbidity as monitoring indicators because they are collected routinely, are comparable over time, and are disaggregated by administrative level. Figure 1 summarizes the three phases of BOD development from inception to institutionalization and its contributions to policy uses.
Discrepancies between GHEs and NHEs
The World Health Reports 1999Á2004 include DALY estimates globally and by WHO region (39Á44). The GBD 2010 reports estimates of deaths and DALYs by cause for individual countries. Since then, the GHE publication has been produced annually (6) . The GBD estimates are useful for comparing and benchmarking across countries. However, the BOD profiles estimated by the GBD are quite different from the Thai estimates with respect to both methodology and findings.
First, the Thai BOD used 2009 as reference year, whereas GBD used the dataset for 2010. Second, GBD 2010 adopted a more sophisticated estimation approach than the Thai BOD, which used the recommended methods provided by the 1990 GBD. The GBD 2010 used modified methods such as a new reference standard life table and age classification, no age weights and no discount rate for years of life lost (formerly use 3% per annum), a prevalence non-fatal burden approach, and more detailed classification of disease sequelae (45) . All of these modifications resulted in divergent estimates of health priorities from the two sources. Table 2 compares estimates of YLLs from the 2009 Thai BOD and the 2010 GBD reports (46) . The GBD revealed that HIV/AIDS was the leading cause of YLL, whereas the Thai BOD reported road traffic injuries as the leading cause of DALYs, with HIV/AIDS ranked fifth. In 2015, meetings between the BOD program and GBD teams generated much discussion on the inaccuracy of GBD estimates, particularly for HIV/AIDS. Furthermore, although the GBD presented data on the change of disease burden pattern between 1990 and 2010, it did not capture the reduction of HIV/AIDS deaths due to universal coverage of antiretroviral therapy (ART) since 2005. Evidence shows that high coverage of universal ART improved quality of life among people living with HIV/AIDS and drastically reduced HIV/AIDS-related mortality (47Á49). Some general conclusions emerged from the discussions. One generalization was that the increasing complexity of the GBD approach was not readily replicable in countries. Another generalization was that the GBD statistical models tended to have considerable inertia so that recent changes in country health indicators were not fully captured. In fact, it was noted that the underlying data upon which the GBD models were developed did not reflect all available empirical data in country. Conflicting results from GBD and country disease profiles can create confusion among policymakers, as was the case in Thailand.
Feedback and verification loop
A commonly expressed concern at country level was the lack of adequate consultation with countries for verification, feedback, and reality checking. The GBD, based on statistical modeling and incorporating multiple assumptions, often introduced changes to the methodologies in response to scientific inputs, but without giving any consideration to the impact such changes would have on the policy relevance and utility of the results to countries. The absence of consultation, verification, and reality check with country partners was a factor in inhibiting the use of the GBD estimates by country experts and decision-makers. More recently, the WHO and Institute for Health Metrics and Evaluation have offered more opportunities for country feedback, which is greatly welcomed.
Inconsistent estimates over time
Another source of confusion could occur when the new update estimates become available and the new set of estimations is produced. Such an example is the trends in maternal mortality estimates developed by the WHO, United Nations Children's Fund, United Nations Population Fund, World Bank, and United Nations Population Division (50Á52). In Thailand, the latest estimate of annual change between 1990 and 2013 was (2%, whereas that between 1990 and 2010 was (0.6%. Although it was stated that the latest estimates should not be compared to or extrapolated from previously published estimates, it would be rather problematic to use new estimates every time they were produced. Table 3 compares strengths and limitations of GHEs and NHEs. The GBD produces comparable statistics across countries by using same methods of estimation and thus facilitates country benchmarking and monitoring progress. GHEs bring together strong technical capacities and are well funded. GHEs, however, do not capture the subnational level information that is much needed by policymakers for specific policy intervention. The availability of GHEs may hamper country commitment to develop capacities to produce NHEs.
Strengths and limitations of GHEs and NHEs
NHEs, using different methods, are neither designed for benchmarking across countries nor designed to support global tracking. The ownership of NHEs and subnational estimates contribute to specific policy interventions. Policy demand for NHEs supports sustainability and its quality improvement. The major limitation is lack of institutional capacities to develop and sustain NHEs in most low-and middle-income countries.
Lessons learned
Use of NHEs for policy decision, monitoring, and evaluation and reprogramming The DALY, a summary health measure at the population level, is useful for priority setting in policy formulation and for monitoring health outcomes in policy implementation. The production and use of the DALY at the global policy platform raises awareness and attention among national policymakers. The GHE plays an important role in stimulating Thai policymakers to have accurate data for decision-making. The knowledge and understanding of the estimates among policymakers and relevant technocrats through a series of meetings and workshops facilitated the use of national BOD estimates and generated the culture of using evidence for policymaking. Furthermore, interactive platforms relevant to country contexts and a sense of ownership of the national estimates has proved far more useful in supporting the use of the DALY in policy formulation than the GHE that is generated from outside agencies without interaction with country partners.
Relevance of GHEs to country reality
Although the GHE attempts to provide accurate health measurement across the globe, it may overlook some country-specific issues. The 1990 GBD did not single out certain diseases that are of relevance in many countries. For example, leptospirosis was prevalent among Thai farmers, but it was not included in the GBD's disease lists. Likewise, thalassemia, a genetic disease prevalent in Thailand, was not covered by the GBD. With country capacities to estimate and the availability of data, both diseases were fully covered in the 1999 Thai BOD estimates.
The number of YLLs from HIV/AIDS in the GBD 2010 is very different from that of the 2009 national BOD estimates. As noted, the GBD estimates fail to reflect the significant mortality reductions after the inclusion of ART in the universal coverage program in 2005.
Institutional capacity building
Strengthening research capacity in low-and middleincome countries is one of the prerequisites for achieving development goals (53). The experience of Thailand has shown that country capacity building and institutionalization of NHE is the key for improving accuracy of country data, maximizing its use in decision-making; thus, it contributes to the estimate's purpose for health improvement.
Building and sustaining institutional capacity of country agencies to generate and use NHEs is the cutting edge in prioritizing policies. Imbalanced investments by donor agencies favoring GHE result in lost opportunities to strengthen country capacities to estimate and use evidence for priority setting, and they create dependency on GHE estimates that may not always correctly reflect country realities.
Whereas global attention to GHE may trigger a country's awareness of the need for better data, those countries promoting GHEs have yet to move the agenda beyond 'in house estimate and modeling' to 'out house empowering' the country partners, and to work closely with them to verify and check the reality.
Unfinished agenda: quality of CODs Given that both NHEs and GHEs rely heavily on death data from civil registration systems, it is vital that countries improve the completeness and quality of death registration and ascertainment of CODs at both health facility and community levels. The Health Metrics Network guidelines on self-assessment of civil registration and vital statistics (CRVS) systems (54) offered an initial step in this direction, but much more needs to be done. Country ownership of NHEs is a prerequisite for policy use. Recent regional and global initiatives will increase the awareness of policymakers of their obligations to strengthen CRVS (55) .
In Thailand, despite extensive coverage of health services and local civil registration offices, little progress has been made on improving the quality of COD ascertainment. The MOPH responsible unit has undertaken several measures and initiatives as described herein. Unfortunately, the COD has not been perceived as a priority in the national health development plans; the unit has received limited financial support and has limited staff. Despite the lack of active support for implementation to improve COD in the vital registration systems, the training of registrars and local health workers in the use of VA for out-of-hospital deaths resulted in increased awareness of the needs for accurate COD ascertainment. Thus, between 1999 when the first VA study was conducted and 2014, the proportion of illdefined codes of COD decreased from 53% in 1999 to 31% in 2014 (45% of total home deaths, 13% of total hospital deaths).
Monitoring health-related SDGs requires representative and comparable estimates. This approach essentially relies on quality of local data, which is often limited in developing countries. A key challenge is premature mortality from NCDs, an indicator that requires good quality of COD data. Mortality from NCDs usually occurs in older age groups, and from our data it is often misclassified as pneumonia and septicemia. Although the data accuracy is improving over time, such mortality-reporting data can create problems in monitoring SDG progress.
Prioritizing actions over measurement
Although setting and achieving health targets are essential, there is more work to do with identifying effective interventions to meet these targets. The latter needs commitments of time and programmatic effort and should not be superseded by how best and accurately to quantify key indicators. Although the national average of health outcomes masks health inequities at the subnational level, there is a need to identify measurable indicators at the subnational level to which the NHEs can contribute.
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The way forward This paper points to the importance of NHEs in informing policy. A few synergistic actions are required to strengthen capacities on an advancement of NHEs. For example, improvement of data platforms, in particular, the CRVS and population-based health surveys by national statistic agencies for monitoring achievement of SDGs; and improvement of capacity in data analysis and translation of data into policy messages and improved capacity to link evidence and use for policymaking.
The development of NHEs requires consultative meetings with local stakeholders, including clinicians, epidemiologists, data authorities, and disease control program officers. This consultive approach gives opportunities for data feedback, leading to data improvement. Because measurement and analytical skills in low-and middleincome countries are limited, collaboration with academic institutions and support from global health and development partners are essential.
Conclusions
Our study has shown that accurate NHEs not only contribute to policy utility in country but also to GHEs. GHEs may benefit global actors and development partners by providing a benchmark across countries on SDG achievements. They also may trigger countries to improve their data systems, strengthen data analysis, and rigorously validate empirically reported data. However, it is essential that a country should have a functioning HIS that supports the production of empirical data. Although the development partner resources are often directed toward the generation of representative health estimates required for planning and monitoring, equal attention should be given to strengthening country capacity for national and subnational health estimates. Generating health estimates that do not link with accountability would be less useful and a waste of resources.
